Payer Perspectives

Panelists discuss the clinical and economic burden of lupus nephritis, strategies for optimizing its management through early diagnosis and updated guidelines, and the importance of multidisciplinary care and collaboration between health care providers and payers to improve patient outcomes and access to treatment.

Ryan Haumschild, PharmD, MBA, leads a discussion with Heidi Crayton, MD, and Maria Lopes, MD, on the current treatment landscape for multiple sclerosis, novel therapies, step therapy, and guidelines for disease management.

Casey Butrus, PharmD; Michael Cameron, MD, FAAD, and Brittany Craiglow, MD, explore the advancement of topical treatments and treatment sequencing for atopic dermatitis (AD), while also providing valuable insights from the payer's perspective.

Experts discuss financial considerations driving RSV treatment in pediatric patients.

Expert panelists provide payer considerations pertaining to the treatment of MDD.